Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NDA application submitted for Orphan Medical's Busulfex injection

Aug. 28, 1998

Novel antitumor antibiotics isolated from Streptomyces by Japanese researchers

Aug. 28, 1998

New compounds for reversing MDR reported by Nikken Chemicals

Aug. 27, 1998

Bavarian Nordic becomes first in Europe to conduct clinical trials of cancer gene therapy

Aug. 27, 1998

NDA application for Temodal submitted to the FDA

Aug. 27, 1998

Pacific Pharmaceuticals and NCI to collaborate in clinical studies of chemosensitizing agent

Aug. 27, 1998

Aphton patents its vaccine-like technology based on the neutralization of gastrin

Aug. 26, 1998

International team identifies compounds for treating slow-growing tumors

Aug. 26, 1998

Onconase inhibits cancer cell growth and contributes to apoptosis

Aug. 25, 1998

More asiatic acid derivatives in development at Dong Kook

Aug. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...